Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel
LON:HLN

Haleon Interim Earnings Report

Haleon logo
GBX 350.20 -5.40 (-1.52%)
As of 12:18 PM Eastern
ProfileEarnings HistoryForecast

Haleon EPS Results

Actual EPS
GBX 8.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Haleon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Haleon Announcement Details

Quarter
Interim
Date
7/31/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Haleon Earnings Headlines

Royal Bank Of Canada Raises Haleon (LON:HLN) Price Target to GBX 390
August 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30957152
Goldman Sachs Reaffirms Their Buy Rating on Haleon PLC (HLN)
August 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HLN-N/pressreleases/3590295/goldman-sachs-reaffirms-their-buy-rating-on-haleon-plc-hln/
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
August 17 at 1:00 AM  |  Investors Alley (Ad)
Berenberg Bank Raises Haleon (LON:HLN) Price Target to GBX 514
August 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30945739
Haleon Updates Share Capital and Voting Rights Structure
August 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-updates-share-capital-and-voting-rights-structure?utm_source=marketbeat.com&utm_medium=referral
Sensodyne maker Haleon slips as sales growth concerns overshadow profit beat
July 30, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/sensodyne-maker-haleon-posts-higher-second-quarter-organic-revenue-growth-2026-07-30/
See More Haleon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Haleon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haleon and other key companies, straight to your email.

About Haleon

Haleon (LON:HLN) (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

View Haleon Profile
Earnings Tools